Candel Therapeutics, Inc. entered into a purchase and sale agreement on February 19, 2026, announced via press release. The Company also provided preliminary cash and cash equivalents as of December 31, 2025.
Key takeaways
Entered into purchase and sale agreement on February 19, 2026
Issued press release on February 19, 2026 announcing the Purchase Agreement
Provided preliminary cash and cash equivalents as of December 31, 2025
Exhibit 99.1: Press Release dated February 19, 2026